Showing 1861-1870 of 5603 results for "".
Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers
https://reachmd.com/programs/cme/bronchiectasis-update-diagnostic-innovations-and-therapeutic-frontiers/37233/Bronchiectasis is complex, often underdiagnosed, and frequently misunderstood. Explore key contributors to disease progression, including the role of neutrophilic inflammation and neutrophilic serine proteases, and learn to distinguish bronchiectasis from other respiratory conditions and assess patiThe Role of Multidisciplinary Care in LGMD2I/R9
https://reachmd.com/programs/cme/the-role-of-multidisciplinary-care-in-lgmd2ir9/35880/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Evidence Builds for Cell-Based Influenza Vaccines
https://reachmd.com/programs/medical-industry-feature/evidence-cell-based-influenza-vaccines/36269/Randomized controlled trials have shown data supporting the safety and efficacy of cell-based influenza vaccines in adults and children.1-4 However, effectiveness studies have historically relied on outcomes based on clinical diagnosis of influenza-like illness rather than test-confirmed influenza.5Making Melanoma Diagnosis and Treatment More Predictable
https://reachmd.com/topics/skin-cancer-photoprotection/making-melanoma-diagnosis-and-treatment-more-predictable/37102/Melanoma can be a very humbling disease. Some of the most talented doctors have been challenged over the years when diagnosing and planning treatment for melanoma because of its variability.Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
https://reachmd.com/programs/project-oncology/subcutaneous-pembrolizumab-in-mnsclc-a-potential-shift-in-the-delivery-landscape/36398/Unlocking Early Detection of IgA Nephropathy: The Critical Role of Timely Diagnosis
https://reachmd.com/programs/frontlines-iga-nephropathy/unlocking-early-detection-of-iga-nephropathy-the-critical-role-of-timely-diagnosis/26945/Here’s how early identification of IgA nephropathy can improve patient outcomes.Depression from Case to Clinic: Rethinking Partial Response with a Different Approach
https://reachmd.com/programs/medical-industry-feature/depression-from-case-to-clinic-rethinking-partial-response-with-a-different-approach/54264/Many clinicians have seen a patient who’s had a partial response to antidepressants but is still struggling with the complexity of their depression. Because depression involves multiple biological systems, these therapies may not fully restore the biochemical balance needed for optimal neurotransmitAldosterone-Targeted Therapies for Uncontrolled Hypertension in Chronic Kidney Disease
https://reachmd.com/programs/cme/aldosterone-targeted-therapies-for-uncontrolled-hypertension-in-chronic-kidney-disease/56405/Chronic kidney disease (CKD) and high blood pressure (BP) are closely linked and, when not managed appropriately, can lead to serious outcomes such as myocardial infarction, stroke, heart failure, and progression to kidney failure. Pathological excess of aldosterone induces hypertension by forcingRecognizing Methamphetamine-Associated PAH: Strategies for Complex Care
https://reachmd.com/programs/deep-breaths-updates-chest/meth-associated-pah-complex-care/39672/Subtle symptoms and overlooked risk factors can delay diagnosis of methamphetamine-associated pulmonary arterial hypertension (PAH), especially given regional differences in clinical practice and access to care. Dr. Rodolfo Estrada speaks with Drs. Steven Hollenberg and Dana Kay about improving clinApplying Evidence to Clinical Practice
https://reachmd.com/programs/cme/applying-evidence-to-clinical-practice/36183/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.